A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes

HPB · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles